Therapeutic monoclonal antibodies (mAbs) and CAR T cell-based immunotherapies are revolutionizing the treatment landscape in MM. Examples include, but are not limited to, monoclonal antibodies targeting CD38, bispecific antibodies targeting GPRC5D × CD3, and BCMA × CD3. Despite being in clinical use, the molecular binding mechanisms of antibodies and the target antigens remain elusive. The prospective doctoral candidate will be trained and is expected to design and implement advanced fluorescence imaging experimental workflows (SMLM and/or lightsheet and/or expansion microscopy) with the aim of discerning the intricate spatial organization of BCMA and GPRC5D antigens on MM cell membranes when treated with traditional and bispecific mAbs, with the final aim of understanding mechanisms of antigen escape in MM treatment.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 9
- Comments 0